Annual Short Term Debt
$1.45 M
-$135.00 K-8.54%
December 31, 2023
Summary
- As of February 8, 2025, TGTX annual short term debt is $1.45 million, with the most recent change of -$135.00 thousand (-8.54%) on December 31, 2023.
- During the last 3 years, TGTX annual short term debt has fallen by -$22.40 million (-93.94%).
- TGTX annual short term debt is now -93.94% below its all-time high of $23.85 million, reached on December 31, 2020.
Performance
TGTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.23 M
-$75.00 K-5.74%
September 30, 2024
Summary
- As of February 8, 2025, TGTX quarterly short term debt is $1.23 million, with the most recent change of -$75.00 thousand (-5.74%) on September 30, 2024.
- Over the past year, TGTX quarterly short term debt has dropped by -$152.00 thousand (-10.99%).
- TGTX quarterly short term debt is now -96.11% below its all-time high of $31.66 million, reached on March 31, 2021.
Performance
TGTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TGTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.5% | -11.0% |
| 3 y3 years | -93.9% | -18.6% |
| 5 y5 years | +100.0% | -18.6% |
TGTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | at low | -49.0% | at low |
| 5 y | 5-year | -93.9% | at low | -96.1% | at low |
| alltime | all time | -93.9% | -100.0% | -96.1% | -100.0% |
TG Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.23 M(-5.7%) |
| Jun 2024 | - | $1.31 M(-5.6%) |
| Mar 2024 | - | $1.38 M(-4.4%) |
| Dec 2023 | $1.45 M(-8.5%) | $1.45 M(-2.2%) |
| Sep 2023 | - | $1.48 M(-2.2%) |
| Jun 2023 | - | $1.51 M(-2.2%) |
| Mar 2023 | - | $1.55 M(-2.2%) |
| Dec 2022 | $1.58 M(-34.5%) | $1.58 M(-2.2%) |
| Sep 2022 | - | $1.62 M(+9.2%) |
| Jun 2022 | - | $1.48 M(-0.8%) |
| Mar 2022 | - | $1.49 M(-38.1%) |
| Dec 2021 | $2.41 M(-89.9%) | $2.41 M(-86.2%) |
| Sep 2021 | - | $17.47 M(-29.2%) |
| Jun 2021 | - | $24.66 M(-22.1%) |
| Mar 2021 | - | $31.66 M(+32.8%) |
| Dec 2020 | $23.85 M(+1375.7%) | $23.85 M(+47.2%) |
| Sep 2020 | - | $16.20 M(+83.0%) |
| Jun 2020 | - | $8.86 M(+452.7%) |
| Mar 2020 | - | $1.60 M(-0.9%) |
| Dec 2019 | $1.62 M(>+9900.0%) | $1.62 M(+18.4%) |
| Sep 2019 | - | $1.36 M(+6.4%) |
| Jun 2019 | - | $1.28 M(+1.7%) |
| Mar 2019 | - | $1.26 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $91.00 K(-56.7%) |
| Jun 2018 | - | $210.00 K(-6.3%) |
| Mar 2018 | - | $224.00 K(+75.0%) |
| Dec 2017 | $128.00 K(+85.8%) | $128.00 K(-29.7%) |
| Sep 2017 | - | $182.20 K(+19.4%) |
| Jun 2017 | - | $152.60 K(-12.7%) |
| Mar 2017 | - | $174.70 K(+153.6%) |
| Dec 2016 | $68.90 K | $68.90 K(-41.2%) |
| Sep 2016 | - | $117.10 K(+29.2%) |
| Jun 2016 | - | $90.60 K(-40.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $152.90 K(-27.7%) |
| Dec 2015 | $211.50 K(-23.1%) | $211.50 K(+16.4%) |
| Sep 2015 | - | $181.70 K(-38.5%) |
| Jun 2015 | - | $295.40 K(+8.5%) |
| Mar 2015 | - | $272.20 K(-1.1%) |
| Dec 2014 | $275.20 K(-59.4%) | $275.20 K(+50.3%) |
| Sep 2014 | - | $183.10 K(+15.0%) |
| Jun 2014 | - | $159.20 K(-76.5%) |
| Dec 2013 | $677.80 K(0.0%) | $677.80 K(0.0%) |
| Sep 2013 | - | $677.80 K(0.0%) |
| Jun 2013 | - | $677.80 K(0.0%) |
| Mar 2013 | - | $677.80 K(0.0%) |
| Dec 2012 | $677.80 K(-22.8%) | $677.80 K(0.0%) |
| Sep 2012 | - | $677.80 K(0.0%) |
| Jun 2012 | - | $677.80 K(0.0%) |
| Mar 2012 | - | $677.80 K(-22.8%) |
| Dec 2011 | $877.80 K(-57.3%) | $877.80 K(+15.3%) |
| Sep 2011 | - | $761.30 K(-1.8%) |
| Jun 2011 | - | $775.30 K(-66.4%) |
| Mar 2011 | - | $2.31 M(+12.4%) |
| Dec 2010 | $2.05 M(+61.2%) | $2.05 M(+0.9%) |
| Sep 2010 | - | $2.04 M(+1.2%) |
| Jun 2010 | - | $2.01 M(+1.2%) |
| Mar 2010 | - | $1.99 M(+56.1%) |
| Dec 2009 | $1.27 M(+1720.1%) | $1.27 M(>+9900.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | $70.00 K(-91.3%) | $70.00 K(0.0%) |
| Sep 2008 | - | $70.00 K(0.0%) |
| Sep 2003 | - | $70.00 K(0.0%) |
| Jun 2003 | - | $70.00 K(0.0%) |
| Mar 2003 | - | $70.00 K(-91.3%) |
| Dec 2002 | $806.00 K | $806.00 K |
FAQ
- What is TG Therapeutics annual short term debt?
- What is the all time high annual short term debt for TG Therapeutics?
- What is TG Therapeutics annual short term debt year-on-year change?
- What is TG Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for TG Therapeutics?
- What is TG Therapeutics quarterly short term debt year-on-year change?
What is TG Therapeutics annual short term debt?
The current annual short term debt of TGTX is $1.45 M
What is the all time high annual short term debt for TG Therapeutics?
TG Therapeutics all-time high annual short term debt is $23.85 M
What is TG Therapeutics annual short term debt year-on-year change?
Over the past year, TGTX annual short term debt has changed by -$135.00 K (-8.54%)
What is TG Therapeutics quarterly short term debt?
The current quarterly short term debt of TGTX is $1.23 M
What is the all time high quarterly short term debt for TG Therapeutics?
TG Therapeutics all-time high quarterly short term debt is $31.66 M
What is TG Therapeutics quarterly short term debt year-on-year change?
Over the past year, TGTX quarterly short term debt has changed by -$152.00 K (-10.99%)